Patient P-01495
Synthetic patientNBL-101 · Day 104 · 65–74 · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
8%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S07
- Day 47 BR-03 recommended — Behavioural Recommendation BR-03
- Day 48 Patient accepted — Started BR-03 in the companion
- Day 55 GI symptom burden −13% vs expected — Behavioural Recommendation BR-03
- Day 61 Tolerance state changed — Unstable → Improving
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-7
- Nutritional resilience+3
- Treatment adherence-3
- Toxicity+3
What helped?
- Behavioural Recommendation BR-03Day 47Result: symptom burden −13%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion16.7/100
worsening · +0.8 vs previous 14 d
Toxicity
Blood10/100
worsening · +0.7 vs previous 14 d
Sleep quality
Wearable52.3/100
stable · -0.1 vs previous 14 d
Energy level
Daily log7.3/10
stable · -0.1 vs previous 14 d
Stress level
Daily log3.5/10
improving · -0.3 vs previous 14 d
Steps
Wearable9,009
stable · +119 vs previous 14 d
Adherence
Companion97 %
stable · +0.7 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 93 from the failing basin, 8 from restoration.
Good elements to keep
- Behavioural Recommendation BR-03intervention · steering +21.3
- Butyrate producers intacthidden · steering +7.5
Main detractors to watch
- Bacteroides fragilis elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+2.2no signal · 40%
- Simple carbohydrates+1.3no signal · 34%
- Spicy / capsaicin-1.1no signal · 33%
- Insoluble fibre-0.9no signal · 21%
- Dietary fat load+0.5no signal · 15%
- Histamine load-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 32 ms, trending down
- Autonomic recovery ↓25
- WearableResting HR 74 bpm
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.1 · butyrate capacity 61/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 36 ms
- Sleep
- 7.1 h
- Steps
- 8,798
- Resting HR
- 74 bpm
Daily log: GI score 17, nutritional resilience 71, adherence 97.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.